Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
196 participants
INTERVENTIONAL
2005-02-28
2005-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
peppermint water
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Discharged before an interview or had preterm delivery
* Postpartum fever
* Breast infection
* Nipple abnormalities
* Age less than 18 years
* Twins
* Taking medications at night
* Mothers who didn't have telephone line, and who were illiterate.
* Infants who used bottle-feeding or pacifier, or who had mouth infection, or an abnormal short frenulum.
14 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tabriz University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manizheh Sayyah Melli, MD
Role: STUDY_DIRECTOR
Tabriz University of Medical Sciences
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
85-2
Identifier Type: -
Identifier Source: org_study_id